5-苯甲酰基-1-甲基吡咯-3-甲醛 | 161560-66-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 5-苯甲酰基-1-甲基吡咯-3-甲醛
• 英文名称: 2-benzoyl-1-methyl-1H-pyrrole-4-carboxaldehyde
• 英文别名: 1H-Pyrrole-3-carboxaldehyde, 5-benzoyl-1-methyl-；5-benzoyl-1-methylpyrrole-3-carbaldehyde
• CAS: 161560-66-3
• 化学式: C₁₃H₁₁NO₂
• 分子量: 213.236
• InChiKey: VJCOAGCSMLVKRO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  39.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-苯甲酰基-1-甲基吡咯-3-甲醛 在 氢氧化钾 、 铜 、 一水合肼 、 三氯氧磷 作用下， 以 乙醇 、 甲苯 、 苯 为溶剂， 反应 4.23h， 生成 (5-benzyl-1,3-dimethyl-4-octadecanoylpyrrol-2-yl)acetic acid
  参考文献：
  名称：

  Lehr, Matthias, Journal of Medicinal Chemistry, 1997, vol. 40, # 21, p. 3381 - 3392

  摘要：

  DOI：
• 作为产物：
  描述：

  (1-甲基-1H-吡咯-2-基)苯基甲酮 、 1,1-二氯甲醚 在 三氯化铝 作用下， 以 二氯甲烷 为溶剂， 反应 0.25h， 以26%的产率得到5-苯甲酰基-1-甲基吡咯-3-甲醛
  参考文献：
  名称：

  Lehr, Matthias, Journal of Medicinal Chemistry, 1997, vol. 40, # 21, p. 3381 - 3392

  摘要：

  DOI：

文献信息

• [DE] ACYLPYRROLALKANSÄUREN UND INDOL-2-ALKANSÄUREN SOWIE IHRE DERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A2<br/>[EN] ACYLPYRROLE-ALKANOIC ACIDS AND INDOLE-2-ALKANOIC ACIDS PLUS THEIR DERIVATIVES FOR USE AS INHIBITORS OF PHOSPHOLIPASE A2<br/>[FR] ACIDES ACYLPYRROLE-ALCANOIQUES ET INDOLE-2-ALCANOIQUES ET LEURS DERIVES UTILISES COMME INHIBITEURS DE LA PHOSPHOLIPASE A2
  申请人：MERCKLE GMBH CHEM.-PHARM. FABRIK

  公开号：WO1995013266A1

  公开（公告）日：1995-05-18

  (DE) Die Erfindung betrifft neue Acylpyrrolalkansäure-Derivate und Indol-2-alkansäure-Derivate der allgemeinen Formel (I) sowie deren Salze und Ester und deren pharmazeutische Verwendung. Die erfindungsgemäßen Verbindungen sind potente Hemmstoffe der Phospholipase A2 und daher brauchbar zur Prävention und/oder zur Behandlung von Erkrankungen, die durch eine erhöhte Aktivität der Phospholipase A2 verursacht bzw. mitverursacht werden, wie Entzündungen, Schmerz, Fieber, Allergien, Asthma, Psoriasis und Endotoxinschock.(EN) The invention concerns novel acylpyrrole-alkanoic acid derivatives and indole-2-alkanoic acid derivatives of general formula (I), plus their salts and esters, and the pharmaceutical use of such compounds. The compounds described are potent inhibitors of phospholipase A2 and thus usable in the prevention and/or treatment of ailments caused or aggravated by increased activity of phospholipase A2, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxin shock.(FR) L'invention concerne de nouveaux dérivés de l'acide acylpyrrole-alcanoïque et de l'acide indole-2-alcanoïque, de formule générale (I), ainsi que leurs sels et esters et leur utilisation pharmaceutique. Les composés selon l'invention sont de puissants inhibiteurs de la phospholipase A2 et sont donc utilisables pour la prévention et/ou le traitement d'affections provoquées ou aggravées par une activité accrue de la phospholipase A2, telles que inflammations, douleurs, fièvre, allergies, asthme, psoriasis et choc endotoxinique.

  这项发明涉及新的酸尿嘧啶衍生物和stoff-2-酸尿嘧啶衍生物，其通用化学式为(I)，以及它们的盐和酯，同时涉及前述化合物的药用用途。根据本发明描述的化合物是强力抑制磷脂酶A₂的，因此可应用于通过增强磷脂酶A₂活性而导致或加重的病症预防和/or治疗，如炎症、疼痛、发烧、过敏、哮喘、皮疹和端otoxine-Tonburst。
• 3-(4-Aroyl-1-methyl-1<i>H</i>-pyrrol-2-yl)-<i>N</i>-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds through Structure-Based Drug Design and Docking Studies^,
  作者：Rino Ragno、Antonello Mai、Silvio Massa、Ilaria Cerbara、Sergio Valente、Patrizia Bottoni、Roberto Scatena、Florian Jesacher、Peter Loidl、Gerald Brosch

  DOI：10.1021/jm031036f

  日期：2004.3.1

  Aroyl-pyrrole-hydroxy-amides (APHAs) are a new class of synthetic HDAC inhibitors recently described by us. Through three different docking procedures we designed, synthesized, and tested two new isomers of APHA lead compound 3-(4-benzoyl-l-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamide (1), compounds 3 and 4, characterized by different insertions of benzoyl and propenoylhydroxamate groups onto the pyrrole ring. Biological activities of 3 and 4 were predicted by computational tools up to 617-fold more potent than that of I against HDAC1; thus, 3 and 4 were synthesized and tested against both mouse HDAC1 and maize HD2 enzymes. Predictions of biological affinities (K-i values) of 3 and 4, performed by a VALIDATE model (applied on either SAD or automatic DOCK or Autodock results) and by the Autodock internal scoring function, were in good agreement with experimental activities. Ligand/receptor positive interactions made by 3 and 4 into the catalytic pocket, in addition to those showed by 1, could at least in part account for their higher HDAC1 inhibitory activities. In particular, in mouse HDAC1 inhibitory assay 3 and 4 were 19- and 6-times more potent than 1, respectively, and 3 and 4 antimaize HD2 activities were 16- and 76-times higher than that of 1, 4 being as potent as SAHA in this assay. Compound 4, tested as antiproliferative and cytodifferentiating agent.
• Lehr, Matthias, Journal of Medicinal Chemistry, 1997, vol. 40, # 21, p. 3381 - 3392
  作者：Lehr, Matthias

  DOI：——

  日期：——